Myocardial infarction (persistent ST-segment elevation) - bivalirudin (TA230)
NICE recommends bivalirudin as a possible treatment for adults with STEMI who are having percutaneous coronary intervention.
Who can have bivalirudin?
You should be able to have bivalirudin if all of the following apply:
- you are an adult with STEMI
- you are having percutaneous coronary intervention
- you are given bivalirudin with aspirin and clopidogrel.
Why has NICE said this?
NICE looks at how well treatments work, and also at how well they work in relation to how much they cost the NHS. NICE recommended bivalirudin because it works better and costs less than other treatments available on the NHS.
This page was last updated: 09 August 2012
- Web format
- Quick reference guide (PDF)
- Full Guidance (PDF)
- TA230 Bivalirudin ar gyfer cnawdnychiad myocardaidd â chodiad cylchrannau ST: deall canllawiau NICE (fformat MS Word)
Information for the public
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
The published NICE clinical guidance, contains the recommendations for health professionals and NHS bodies.
The published full clinical guidance for specialists with background, evidence, recommendations and methods used.